Moxifloxacin in pharma franchise in Himachal Pradesh

Moxifloxacin in PCD pharma franchise in Shillong

Moxifloxacin in top pharma company in Pune

Moxifloxacin in pcd pharma supplier in Thane

Moxifloxacin in phama franchise company in India
Moxifloxacin in phama distributor in Pimpri-Chinchwad

Home/Products /moxifloxacin-infusion-infusion

Moxolunic IV

Composition : Moxifloxacin IP 400 mg + Mannitol IP 5.0% w/v Infusuion

Dosage Form : Injection

Packaging Type : vial

Packaging : 100 ml

Price : ₹418/-

Moxolunic IV is a highly effective infusion containing Moxifloxacin, a broad-spectrum fluoroquinolone antibiotic. It is specifically designed for the treatment of serious bacterial infections where oral antibiotic therapy is insufficient or not feasible. Moxifloxacin works by targeting bacterial DNA gyrase and topoisomerase IV, enzymes critical for bacterial DNA replication, transcription, and repair. This dual mechanism ensures robust bacterial eradication, making it a reliable choice in clinical settings.

This infusion provides a convenient and potent intravenous delivery, ensuring rapid achievement of therapeutic levels in the bloodstream. Moxolunic IV is particularly beneficial in managing severe infections caused by susceptible bacterial strains, offering high efficacy and rapid symptom relief.

Read More

About the Product

Moxolunic IV is a highly effective infusion containing Moxifloxacin, a broad-spectrum fluoroquinolone antibiotic. It is specifically designed for the treatment of serious bacterial infections where oral antibiotic therapy is insufficient or not feasible. Moxifloxacin works by targeting bacterial DNA gyrase and topoisomerase IV, enzymes critical for bacterial DNA replication, transcription, and repair. This dual mechanism ensures robust bacterial eradication, making it a reliable choice in clinical settings.

This infusion provides a convenient and potent intravenous delivery, ensuring rapid achievement of therapeutic levels in the bloodstream. Moxolunic IV is particularly beneficial in managing severe infections caused by susceptible bacterial strains, offering high efficacy and rapid symptom relief.

Common side effects include nausea, dizziness, diarrhea, or injection site reactions.

Moxolunic IV is used to treat severe bacterial infections, including pneumonia, skin, and intra-abdominal infections.

Use only under medical supervision and complete the prescribed course.

Store below 25°C, protected from light and moisture.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation